BackKorro Bio Overview

Korro Bio Other Assets

Track Korro Bio's other assets ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average / median

Loading

Korro Bio Other Assets History

Loading

Korro Bio vs. peers: Other Assets Comparison

Loading

Korro Bio Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Korro Bio (KRRO) FAQ

Korro Bio (KRRO) currently reports a other assets of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Korro Bio's other assets history and peer comparisons.

Korro Bio's other assets changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Korro Bio reported $0 in other assets as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Korro Bio, and consider following KRRO for alerts when major investors trade the stock.

Korro Bio is classified in the Healthcare sector. On other assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KRRO with unrelated industries.